Latest Breaking News On - Tumor activated immunomodulators - Page 2 : comparemela.com

Janux Therapeutics (NASDAQ:JANX) Price Target Raised to $63 00

Janux Therapeutics (NASDAQ:JANX – Free Report) had its price objective raised by HC Wainwright from $50.00 to $63.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Janux Therapeutics’ Q2 2024 earnings at ($0.38) EPS, Q4 2024 […]

United statesEngagers tractrImmunomodulators tracirChina universal asset management coCerity partnersAllspring global investments holdingsBarclays plcCantor fitzgeraldJanux therapeutics incJanux therapeuticsFree reportTherapeutics stock downGet free reportGlobal investments holdingsUniversal asset managementTumor activatedt cell engagers

Head to Head Analysis: Janux Therapeutics (NASDAQ:JANX) and Lucy Scientific Discovery (NASDAQ:LSDI)

Head to Head Analysis: Janux Therapeutics (NASDAQ:JANX) and Lucy Scientific Discovery (NASDAQ:LSDI)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesImmunomodulators tracirEngagers tractrLucy scientific discovery incHollyweed north cannabis incJanux therapeutics incMerck sharp dohme corpJanux therapeuticsGet free reportLucy scientific discoveryScientific discoveryGiven janux therapeuticLucy scientificTumor activatedt cell engagersTumor activated immunomodulators

HC Wainwright Raises Janux Therapeutics (NASDAQ:JANX) Price Target to $63 00

HC Wainwright Raises Janux Therapeutics (NASDAQ:JANX) Price Target to $63 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesEngagers tractrImmunomodulators tracirWilliam blairSg americas securitiesChina universal asset management coJanux therapeutics incCorton capital incJanux therapeutics company profileNisa investment advisorsCantor fitzgeraldOld well partnersJanux therapeuticsFree reportGet free reportInvestment advisors

Janux Therapeutics (JANX) Overweight Rating Reaffirmed at Cantor Fitzgerald

Janux Therapeutics (JANX) Overweight Rating Reaffirmed at Cantor Fitzgerald
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesImmunomodulators tracirWilliam blairLester murray antmanEngagers tractrLord abbettCantor fitzgeraldJanux therapeutics incProshare advisorsVanguard group incCapstone investment advisorsJanux therapeuticsFree reportGet free reportShare advisorsMurray antman

Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11 5%

Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairImmunomodulators tracirEngagers tractrCorton capital incBarclays plcOld well partnersJanux therapeutics incJanux therapeuticsGet free reportSwell partnersAdage capital partnersCapital partnersTumor activatedt cell engagersTumor activated immunomodulatorsJanux therapeutics daily